Preeclampsia as a risk factor for the development of retinopathy of premature

Abstract

In a review of the literature, maternal preeclampsia has been considered a risk factor for the development and severity of retinopathy of prematurity (RP). Preeclampsia is a complication that occurs in the second half of pregnancy (after 20 weeks), and it is diagnosed when arterial hypertension first appears (BP ≥140/90 mm Hg), proteinuria (≥0.3 g/L in daily urine), edema (not always), multiple organ/multisystem dysfunction/insufficiency, which are based on the dysfunction of the vascular endothelium. ROP remains a potentially vision-threatening condition that requires careful monitoring and timely intervention to prevent the progression of adverse visual impairment or blindness. RP initially presents with delayed physiological retinal vascular development, which is followed by pathological vasoproliferation; this condition is highly correlated with extreme prematurity and poor postnatal growth. This article discusses the possible mechanisms of influence of maternal preeclampsia on the development and severity of ROP in premature babies. A special role is attributed to circulating antiangiogenic factors in the preeclamptic maternal environment, which can influence the development of fetal retinal vessels and predispose premature infants to ROP. Рreeclampsia increases the risk and severity of preterm birth, which are closely related to the risk of ROP. These results are contradictory, as some authors consider preeclampsia as a risk factor for the development of ROP, while others have not yet identified any connection between these processes. However, several authors consider preeclampsia as a protective factor in relation to the development of ROP. Dysregulation of circulating angiogenic factors plays an important role in the pathogenesis of both preeclampsia and ROP. Preeclampsia should therefore be studied further and considered along with other risk factors for ROP.

Keywords

retinopathy of prematurity / preeclampsia / anti-angiogenic factors / vascular endothelial growth factor / a review

References

[1] Dobrokhotova YE, Dzhokhadze LS, Kuznetsov PA, et al. Preeclampsia: from history to the present day. Problemy reproduktsii. 2015;21(5):120–126. (In Russ). doi: 10.17116/repro2015215120-126

[2] Доброхотова Ю.Э., Джохадзе Л.С., Кузнецов П.А., и др. Преэклампсия: от истории до сегодняшнего дня // Проблемы репродукции. 2015. Т. 21, № 5. С. 120–126. doi: 10.17116/repro2015215120-126

[3] Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75(1):1–8. doi: 10.1016/j.mvr.2007.04.009

[4] Mutter W.P., Karumanchi S.A. Molecular mechanisms of preeclampsia // Microvasc Res. 2008. Vol. 75, N 1. P. 1–8. doi: 10.1016/j.mvr.2007.04.009

[5] Sidorova IS, Nikitina NA. Preeclampsia as gestational immune complex complement-mediated endotheliosis. Rossiiskii vestnik akushera-ginekologa. 2019;19(1):5–11. (In Russ). doi: 10.17116/rosakush2019190115

[6] Сидорова И.С., Никитина Н.А. Преэклампсия как гестационный иммунокомплексный комплементопосредованный эндотелиоз // Российский вестник акушера-гинеколога. 2019. Т. 19, № 1. С. 5–11. doi: 10.17116/rosakush2019190115

[7] Gyamfi-Bannerman C, Fuchs KM, Young OM, Hoffman MK. Nonspontaneous late preterm birth: etiology and outcomes. Am J Obstet Gynecol. 2011;205(5):456 e451–456. doi: 10.1016/j.ajog.2011.08.007

[8] Gyamfi-Bannerman C., Fuchs K.M., Young O.M., Hoffman M.K. Nonspontaneous late preterm birth: etiology and outcomes // Am J Obstet Gynecol. 2011. Vol. 205, N 5. P. 456 e451–456. doi: 10.1016/j.ajog.2011.08.007

[9] Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–644. doi: 10.1016/s0140-6736(10)60279-6

[10] Steegers E.A.P., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia // Lancet. 2010. Vol. 376, N 9741. P. 631–644. doi: 10.1016/s0140-6736(10)60279-6

[11] Yu XD, Branch DW, Karumanchi SA, Zhang J. Preeclampsia and retinopathy of prematurity in preterm births. Pediatrics. 2012;130(1):e101–107. doi: 10.1542/peds.2011-3881

[12] Yu X.D., Branch D.W., Karumanchi S.A., Zhang J. Preeclampsia and retinopathy of prematurity in preterm births // Pediatrics. 2012. Vol. 130, N 1. P. e101–107. doi: 10.1542/peds.2011-3881

[13] Yen TA, Yang HI, Hsieh WS, et al. Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study. PLoS One. 2013;8(9):e75168. doi: 10.1371/journal.pone.0075168

[14] Yen T.A., Yang H.I., Hsieh W.S., et al. Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study // PLoS One. 2013. Vol. 8, N 9. P. e75168. doi: 10.1371/journal.pone.0075168

[15] Araz-Ersan B, Kir N, Akarcay K, et al. Epidemiological analysis of retinopathy of prematurity in a referral centre in Turkey. Br J Ophthalmol. 2013;97(1):15–17. doi: 10.1136/bjophthalmol-2011-301411

[16] Araz-Ersan B., Kir N., Akarcay K., et al. Epidemiological analysis of retinopathy of prematurity in a referral centre in Turkey // Br J Ophthalmol. 2013. Vol. 97, N 1. P. 15–17. doi: 10.1136/bjophthalmol-2011-301411

[17] Lee JW, McElrath T, Chen M, et al. Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia. J Matern Fetal Neonatal Med. 2013;26(8):811–818. doi: 10.3109/14767058.2013.764407

[18] Lee J.W., McElrath T., Chen M., et al. Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia // J Matern Fetal Neonatal Med. 2013. Vol. 26, N 8. P. 811–818. doi: 10.3109/14767058.2013.764407

[19] Huang HC, Yang HI, Chou HC, et al. Preeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based Study. PLoS One. 2015;10(11):e0143248. doi: 10.1371/journal.pone.0143248

[20] Huang H.C., Yang H.I., Chou H.C., et al. Preeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based Study // PLoS One. 2015. Vol. 10, N 11. P. e0143248. doi: 10.1371/journal.pone.0143248

[21] Hellstrom A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001;98(10):5804–5808. doi: 10.1073/pnas.101113998

[22] Hellstrom A., Perruzzi C., Ju M., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity // Proc Natl Acad Sci U S A. 2001. Vol. 98, N 10. P. 5804–5808. doi: 10.1073/pnas.101113998

[23] Hellstrom A, Carlsson B, Niklasson A, et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab. 2002;87(7):3413–3416. doi: 10.1210/jcem.87.7.8629

[24] Hellstrom A., Carlsson B., Niklasson A., et al. IGF-I is critical for normal vascularization of the human retina // J Clin Endocrinol Metab. 2002. Vol. 87, N 7. P. 3413–3416. doi: 10.1210/jcem.87.7.8629

[25] Hellstrom A, Engstrom E, Hard AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112(5):1016–1020. doi: 10.1542/peds.112.5.1016

[26] Hellstrom A., Engstrom E., Hard A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth // Pediatrics. 2003. Vol. 112, N 5. P. 1016–1020. doi: 10.1542/peds.112.5.1016

[27] Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683. doi: 10.1056/NEJMoa031884

[28] Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia // N Engl J Med. 2004. Vol. 350, N 7. P. 672–683. doi: 10.1056/NEJMoa031884

[29] Signore C, Mills JL, Qian C, et al. Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008;28(9):852–858. doi: 10.1002/pd.2065

[30] Signore C., Mills J.L., Qian C., et al. Circulating soluble endoglin and placental abruption // Prenat Diagn. 2008. Vol. 28, N 9. P. 852–858. doi: 10.1002/pd.2065

[31] Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers of preeclampsia: a review. Reprod Biol Endocrinol. 2009;7:70. doi: 10.1186/1477-7827-7-70

[32] Grill S., Rusterholz C., Zanetti-Dallenbach R., et al. Potential markers of preeclampsia: a review // Reprod Biol Endocrinol. 2009. Vol. 7, N. P. 70. doi: 10.1186/1477-7827-7-70

[33] Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23. doi: 10.1080/14767050701830480

[34] Romero R., Nien J.K., Espinoza J., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate // J Matern Fetal Neonatal Med. 2008. Vol. 21, N 1. P. 9–23. doi: 10.1080/14767050701830480

[35] Zayed MA, Uppal A, Hartnett ME. New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2010;51(10):4983–4988. doi: 10.1167/iovs.10-5283

[36] Zayed M.A., Uppal A., Hartnett M.E. New-onset maternal gestational hypertension and risk of retinopathy of prematurity // Invest Ophthalmol Vis Sci. 2010. Vol. 51, N 10. P. 4983–4988. doi: 10.1167/iovs.10-5283

[37] Kulkarni AV, Mehendale SS, Yadav HR, et al. Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res. 2010;33(6):561–567. doi: 10.1038/hr.2010.31

[38] Kulkarni A.V., Mehendale S.S., Yadav H.R., et al. Circulating angiogenic factors and their association with birth outcomes in preeclampsia // Hypertens Res. 2010. Vol. 33, N 6. P. 561–567. doi: 10.1038/hr.2010.31

[39] Pratt A, Da Silva Costa F, Borg AJ, et al. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis. 2015;18(2):115–123. doi: 10.1007/s10456-014-9452-3

[40] Pratt A., Da Silva Costa F., Borg A.J., et al. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia // Angiogenesis. 2015. Vol. 18, N 2. P. 115–123. doi: 10.1007/s10456-014-9452-3

[41] Ozkan H, Cetinkaya M, Koksal N, et al. Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity. J Perinat Med. 2011;39(5):523–527. doi: 10.1515/jpm.2011.071

[42] Ozkan H., Cetinkaya M., Koksal N., et al. Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity // J Perinat Med. 2011. Vol. 39, N 5. P. 523–527. doi: 10.1515/jpm.2011.071

[43] Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005. doi: 10.1056/NEJMoa055352

[44] Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia // N Engl J Med. 2006. Vol. 355, N 10. P. 992–1005. doi: 10.1056/NEJMoa055352

[45] Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–487. doi: 10.1161/CIRCULATIONAHA.109.895458

[46] Noori M., Donald A.E., Angelakopoulou A., et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension // Circulation. 2010. Vol. 122, N 5. P. 478–487. doi: 10.1161/CIRCULATIONAHA.109.895458

[47] Staff AC, Braekke K, Harsem NK, et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):33–39. doi: 10.1016/j.ejogrb.2004.11.015

[48] Staff A.C., Braekke K., Harsem N.K., et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia // Eur J Obstet Gynecol Reprod Biol. 2005. Vol. 122, N 1. P. 33–39. doi: 10.1016/j.ejogrb.2004.11.015

[49] Staff AC, Braekke K, Johnsen GM, et al. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol. 2007;197(2):176 e171–176. doi: 10.1016/j.ajog.2007.03.036

[50] Staff A.C., Braekke K., Johnsen G.M., et al. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia // Am J Obstet Gynecol. 2007. Vol. 197, N 2. P. 176 e171–176. doi: 10.1016/j.ajog.2007.03.036

[51] Chan PY, Tang SM, Au SC, et al. Association of Gestational Hypertensive Disorders with Retinopathy of prematurity: A Systematic Review and Meta-analysis. Sci Rep. 2016;6:30732. doi: 10.1038/srep30732

[52] Chan P.Y., Tang S.M., Au S.C., et al. Association of Gestational Hypertensive Disorders with Retinopathy of prematurity: A Systematic Review and Meta-analysis // Sci Rep. 2016. Vol. 6. P. 30732. doi: 10.1038/srep30732

[53] Yau GS, Lee JW, Tam VT, et al. Incidence and Risk Factors of Retinopathy of Prematurity From 2 Neonatal Intensive Care Units in a Hong Kong Chinese Population. Asia Pac J Ophthalmol (Phila). 2016;5(3):185–191. doi: 10.1097/APO.0000000000000167

[54] Yau G.S., Lee J.W., Tam V.T., et al. Incidence and Risk Factors of Retinopathy of Prematurity From 2 Neonatal Intensive Care Units in a Hong Kong Chinese Population // Asia Pac J Ophthalmol (Phila). 2016. Vol. 5, N 3. P. 185–191. doi: 10.1097/APO.0000000000000167

[55] Yang CY, Lien R, Yang PH, et al. Analysis of incidence and risk factors of retinopathy of prematurity among very-low-birth-weight infants in North Taiwan. Pediatr Neonatol. 2011;52(6):321–326. doi: 10.1016/j.pedneo.2011.08.004

[56] Yang C.Y., Lien R., Yang P.H., et al. Analysis of incidence and risk factors of retinopathy of prematurity among very-low-birth-weight infants in North Taiwan // Pediatr Neonatol. 2011. Vol. 52, N 6. P. 321–326. doi: 10.1016/j.pedneo.2011.08.004

[57] Alshaikh B, Salman O, Soliman N, et al. Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation. BMJ Open Ophthalmol. 2017;1(1):e000049. doi: 10.1136/bmjophth-2016-000049

[58] Alshaikh B., Salman O., Soliman N., et al. Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation // BMJ Open Ophthalmol. 2017. Vol. 1, N 1. P. e000049. doi: 10.1136/bmjophth-2016-000049

[59] Fortes Filho JB, Costa MC, Eckert GU, et al. Maternal preeclampsia protects preterm infants against severe retinopathy of prematurity. J Pediatr. 2011;158(3):372–376. doi: 10.1016/j.jpeds.2010.08.051

[60] Fortes Filho J.B., Costa M.C., Eckert G.U., et al. Maternal preeclampsia protects preterm infants against severe retinopathy of prematurity // J Pediatr. 2011. Vol. 158, N 3. P. 372–376. doi: 10.1016/j.jpeds.2010.08.051

[61] Yau GS, Lee JW, Tam VT, et al. Incidence and risk factors for retinopathy of prematurity in extreme low birth weight Chinese infants. Int Ophthalmol. 2015;35(3):365–373. doi: 10.1007/s10792-014-9956-2

[62] Yau G.S., Lee J.W., Tam V.T., et al. Incidence and risk factors for retinopathy of prematurity in extreme low birth weight Chinese infants // Int Ophthalmol. 2015. Vol. 35, N 3. P. 365–373. doi: 10.1007/s10792-014-9956-2

RIGHTS & PERMISSIONS

Eco-Vector